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Abstract
Background: Randomized controlled trials play a central role in evidence-based practice, but recruitment of
participants, and retention of them once in the trial, is challenging. Moreover, there is a dearth of evidence that
research teams can use to inform the development of their recruitment and retention strategies. As with other
healthcare initiatives, the fairest test of the effectiveness of a recruitment strategy is a trial comparing alternatives,
which for recruitment would mean embedding a recruitment trial within an ongoing host trial. Systematic reviews
indicate that such studies are rare. Embedded trials are largely delivered in an ad hoc way, with interventions almost
always developed in isolation and tested in the context of a single host trial, limiting their ability to contribute to a
body of evidence with regard to a single recruitment intervention and to researchers working in different contexts.
Methods/Design: The Systematic Techniques for Assisting Recruitment to Trials (START) program is funded by the
United Kingdom Medical Research Council (MRC) Methodology Research Programme to support the routine
adoption of embedded trials to test standardized recruitment interventions across ongoing host trials. To achieve
this aim, the program involves three interrelated work packages: (1) methodology - to develop guidelines for the
design, analysis and reporting of embedded recruitment studies; (2) interventions - to develop effective and useful
recruitment interventions; and (3) implementation - to recruit host trials and test interventions through embedded
studies.
Discussion: Successful completion of the START program will provide a model for a platform for the wider trials
community to use to evaluate recruitment interventions or, potentially, other types of intervention linked to trial
conduct. It will also increase the evidence base for two types of recruitment intervention.
Trial registration: The START protocol covers the methodology for embedded trials. Each embedded trial is
registered separately or as a substudy of the host trial.
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Background
Fundamental to health research is the testing of inter-
ventions through trials. Although many thousands of tri-
als have been conducted, it is well known that achieving
high levels of professional and patient participation in
randomized controlled trials is often problematic. Many
trials fail to recruit sufficient numbers of patients, or at
least fail to do so in a timely fashion [1-4]. Other trials
may reach recruitment targets by approaching large
numbers of potential participants, but only recruit a
small proportion of those actually eligible, with implica-
tions for both resources and bias. Recruitment problems
can reduce the total recruited sample (limiting statistical
power) and the proportion of eligible participants who
participate (limiting external validity). Poor recruitment
means a trial runs the risk of being underpowered and
clinically relevant results may be reported as statistically
non-significant, increasing the chance that an effective
intervention will either be abandoned before its true
value is established, or at the very least, delayed as fur-
ther trials or meta-analyses are conducted. Recruitment
is seen as the methodological research priority for clin-
ical trials units in the United Kingdom [5].
Qualitative researchers have explored the recruitment
process in depth [6-8], highlighting factors that could
potentially act as levers for improving practice, including
communications between lead researchers and other
staff, and time and resource for governance. Key insights
can be gained from such work, and can serve as the
basis for the development of recruitment interventions
[9,10]. However, these designs are not suited for the
evaluation of the effect of interventions on recruitment.
For that, the most robust test of the effectiveness of a re-
cruitment method is a trial comparing one method with
an alternative, embedded in a real host trial. Embedding
means that patients being recruited to an ongoing trial
are additionally randomized to one of the two or more
alternative recruitment strategies being evaluated. Such
studies allow an unbiased assessment of the effectiveness
of the recruitment intervention on a variety of recruit-
ment outcomes, such as total numbers recruited, the
proportion taking part, and the cost and efficiency of the
recruitment process. Moreover, because the evaluation is
embedded within an ongoing trial, the method evaluates
the strategies in the context of a real decision to take
part or not by potential participants.
The acceptance of the trial as the bedrock of outcomes
research has led to a vast number of trials conducted
(over 790,000 records on the Cochrane central register
of controlled trials (CENTRAL) as of June 2014). Given
the size of this potential platform for recruitment stud-
ies, and the consensus among the research community
concerning the challenge of recruitment, it is surprising
that embedded trials of recruitment interventions remain
so rare. The Cochrane review on recruitment interven-
tions identified only 45 embedded studies in real and
hypothetical trials [11,12] and concluded that ‘it would be
better if more researchers included an evaluation of re-
cruitment strategies in real trials’. The failure to grasp this
opportunity means that recruitment for science is not
underpinned by a science of recruitment.
Although a general increase in the number of embedded
trials would be welcome, a more ambitious approach
might extend the evidence base more systematically and
rapidly. This would involve embedding the routine use of
embedded recruitment trials in the research funding
process, so that embedded trials are an accepted part of
the delivery of all trials, adopted by a significant propor-
tion of principal investigators as part of a wider endeavor
across the trials community. This would be akin to the
way in which patient and public involvement has become
routinely embedded in health research [13]. Achieving this
would not only rapidly develop the evidence base, it would
also have the advantage of enabling similar recruitment in-
terventions to be tested across multiple trials, allowing a
clearer assessment of their general utility, and their sensi-
tivity to contextual factors such as clinical populations,
and interventions under test, setting, or time.
Although attractive in principle, the low frequency of
use of embedded studies suggests that barriers exist.
Qualitative work with key stakeholders (principal investi-
gators, research managers, research ethics committee
chairs, and funding representatives) has highlighted sev-
eral challenges [14]. Although respondents recognized
the case for embedded recruitment studies, their enthu-
siasm was tempered by a number of issues in imple-
menting such studies in routine practice. Perceived
challenges for host studies included increased manage-
ment burden in addition to the testing requirements of
the main trial, potential incompatibility between the host
and embedded study, and the impact of the embedded
study on trial design and relationships with collaborators.
For embedded recruitment studies, there were concerns
that host investigators might have strong preferences
about one of the recruitment interventions under test,
limiting the embedded study investigators’ control over
the delivery of the embedded study. Overall, research on
recruitment was welcomed in principle, but raised issues
concerning control.
The START study (funded by the Medical Research
Council (MRC) Methodology Research Programme) is
designed to develop the conceptual, methodological, and
logistical framework to make embedded recruitment tri-
als a routine part of the delivery of trials, and to test this
approach by developing a small number of recruitment
interventions and testing them across multiple host tri-
als. Our long-term aim is to support more efficient trials
by improving the evidence base concerning recruitment
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to trials, and thus enhance recruitment rates, make bet-
ter use of health research resources and, ultimately, sup-
port improvement in patient health.
Aims
The aim of the START program is to develop a meth-
odological framework and process of implementation for
developing and testing embedded recruitment interven-
tions within ongoing host trials. To achieve this, the
program involves three work packages: (1) methodology -
developing guidelines for the design, analysis and report-
ing of embedded studies, developing resources for those
planning embedded studies, including, templates for em-
bedded study protocols, embedded study registration, data
sharing, and publication agreements; (2) interventions -
developing recruitment interventions for embedding; and
(3) implementation - recruitment of principal investigators
of potential host trials, embedding of our recruitment in-




The initial focus of START is on the recruitment of pa-
tients in primary care and community settings, and in
publically funded trials. This partly reflects the compos-
ition and expertise of the research team, and has influ-
enced the choice of the initial interventions to be tested
within START, as these are suited to the ‘remote’ strat-
egies (such as postal surveys) often used to recruit pa-
tients into primary care and community trials, compared
to the predominance of face-to-face strategies that are
used in secondary care settings. However, the broad
START approach will have wider relevance in a range of
contexts and trial types.
Work package 1: methodology
We will develop a framework for the evaluation of em-
bedded recruitment interventions. This will involve a re-
view of the design issues and statistical methods specific
to studies of embedded recruitment interventions (for
example, where the unit of analysis in host and embedded
studies differ). We will extend the analytic framework to
consider issues such as the analysis of the effects of re-
cruitment interventions across different studies, sites, and
practices. We will also develop guidelines for the measure-
ment of the various outcomes of recruitment inter-
ventions such as: numbers of patients recruited, rate of
recruitment, rate of retention, participant satisfaction,
knowledge of the recruitment process, measures of in-
formed consent and anxiety, sensitivity and/or specificity
of recruitment methods in terms of proportions of eligible
and/or ineligible patients identified, and the cost of re-
cruitment interventions and the recruitment process.
We will develop a framework for the reporting of em-
bedded recruitment studies, exploring the need for ap-
propriate extensions to the Consolidated Standards of
Reporting Trials (CONSORT) guidelines. The initial cri-
teria will be drawn up by going through published reports
of embedded trials assessing the recruitment interven-
tions. Relevant studies will be identified by hand-searching
the reference lists of earlier reviews [12,15-18] on this
topic, and contacting co-applicants for information on
relevant studies known to them. The methodological re-
view will be supported by structured searches of the litera-
ture, complemented by analysis of the methods used in
published trials identified by the earlier reviews [12,15-18].
Work package 2: developing interventions
We chose to test the effects of two recruitment interven-
tions for work package 2. Both interventions related to
the provision of initial information for potential patients,
as opposed to other key aspects of the recruitment
process (such as recruitment of sites or professionals, or
different methods of participant identification [19]). Our
choice was based in part on a qualitative study of re-
search staff perspectives, which found that ‘providing
clear and concise information to potential participants’
was rated as ‘very important’ by 72% of respondents
[20]. There is evidence that existing information in trials
does not support high quality decision-making [21], and
so the testing of enhancements is of high relevance. We
also chose interventions that targeted the same aspect of
the trial process (initial information), but which differed
in content, cost, and complexity, to explore the yield of
different methods which might differ in the ease with
which they might be more widely implemented in trials.
However, the choice also reflected pragmatic issues.
We had existing expertise in these interventions, and
could draw on existing resources. The information pro-
vided to patients is readily modifiable, and such changes
at the patient level can be allocated at random in embed-
ded recruitment studies with comparative ease. In con-
trast, other embedded recruitment interventions, such as
allocating patients to an initial approach from different
professionals [22], or identifying patients using different
methods, pose more significant logistical barriers, which
may not be optimal for early phase feasibility work. Details
of the intervention development process for the two inter-
ventions are described below.
Intervention 1: optimized participant information sheets
Research ethics committees rightly want to ensure that
participants receive appropriate information and are able
to provide fully informed consent. However, a long and
complex participant information sheet (PIS) may impact
negatively on recruitment, particularly if it is also visu-
ally unappealing or raises inappropriate levels of anxiety
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[21]. This is especially critical when patients are initially
approached by a letter from their health professional,
which occurs in a significant proportion of trials in pri-
mary care and community settings, especially in patients
with long-term conditions. A systematic review has
identified evidence that involving consumers in the de-
velopment of patient information results in higher rele-
vance and readability, without increasing anxiety [23].
To test the impact of involving consumers in the de-
velopment of patient information, a revised version of
the PIS will be prepared for each host trial. The process
involves optimization of PIS readability through expert-
ise in writing for patients and improved presentation via
graphic design [24]. The revisions are informed by user
testing [25-27], where the ability of patients to locate
and understand key pieces of information is evaluated
objectively to provide an assessment of the ability of the
PIS to provide information in a way that can be under-
stood. Initially the original PIS is tested, and then ver-
sions of the optimized PIS are tested (followed by
further revision), until the resultant PIS is better able to
inform potential trial participants. The optimized PIS
would cover the same topics as the original version but
the optimized version would likely differ in appearance,
structure, and wording. See Figure 1 for an exemplar of
an original and optimized PIS [25].
Members of the START research team have experi-
ence in this process, and user testing to develop the
optimized PIS will be conducted through a commercial
company (Luto Research Ltd, a University of Leeds
(United Kingdom) spin-out company that provides infor-
mation writing and testing services to the pharmaceutical
Figure 1 Exemplar original (left) and optimized (right) participant information sheets [25].
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industry). It is anticipated that, if successful, this interven-
tion could be funded through additional grant funding for
PIS optimization. Patients in each host trial will then be
randomized to either the original or optimized PIS.
Intervention 2: multimedia concerning participation
in research
At present most information about trial participation is
presented in written form, but this is not necessarily the
best way to communicate complex messages to all
segments of the targeted population, particularly as so
much communication now happens via the internet,
often using video. Multimedia interventions may offer a
useful strategy to improve communication about partici-
pation and may therefore facilitate greater accrual and
retention rates. The diverse methods of information de-
livery possible via multimedia platforms provide alterna-
tive channels for health communication, in particular
the internet provides an opportunity for self-directed
and tailored learning [28-32]. However, the impact of
multimedia information on patient-identified barriers
and motivators to trial participation has not been rigor-
ously explored.
We therefore set out to design and test multimedia ap-
proaches for delivering information to potential research
participants alongside the standard, written PIS [33].
The design process was built on previous qualitative
research [34,35], and a review of research on patient
decision-making conducted by the investigators (Hudson
J, Rick J, Hughes-Morley A, Bower P: What psychosocial
factors are identified by patients as being important
determinants of their decision to participate in clinical
trials and can these be targeted by multimedia interven-
tion? A meta-review: unpublished data), and involved
multiple iterative discussions within the research team.
These deliberations covered the aims and content of the
multimedia interventions, design issues to maximize
relevance and impact, minimizing the burden on poten-
tial participants, how it would be evaluated, and ways to
encourage potential participants to view the resources.
During the design process, the research team drew on
several resources, to test the content and delivery plat-
form for the intervention. Firstly, a workshop was con-
ducted at the Primary Care Research Network (PCRN)
national conference (November 2012), led by a clinician
with considerable PCRN expertise and attended by PCRN
research staff. Secondly, input and feedback was obtained
from two Patient and Public Involvement representatives
from the University of Manchester, Primary Care Research
in Manchester Engagement Resource (PRIMER [36]).
Thirdly, guidance was given from an academic GP work-
ing alongside colleagues from the award-winning charity
healthtalk.org [37] hosted by the University of Oxford. Fi-
nally, expertise was sought from within the MRC START
project team which includes clinicians, psychologists and
experts in trials.
The content was based on relevant theoretical and em-
pirical work about patient decision-making both gener-
ally [38,39] and in trials [40,41]. It was agreed that the
content would not repeat the standard PIS, but be de-
signed specifically to help potential participants make
better informed decisions by providing additional informa-
tion about medical research and trial participation includ-
ing, where possible, information on previous participants’
experiences of medical studies.
To design the web-based platform, the research team
developed a draft specification to outline the three com-
ponents. The first component was a homepage, which
needed to be relevant to each specific host trial, giving a
brief pitch about the trial to engage potential partici-
pants and offering them the options of more information
on medical research in general or, finding more about
the specific trial (see Figure 2). The second component,
generic pages on medical research, included video clips
of previous participants describing their experiences tak-
ing part in medical research, and cover issues of relevance
to potential participants, such as ‘Why get involved?’,
‘Agreeing to take part’, ‘What happens in a study?’, ‘Leaving
a study’, and ‘Protecting privacy’.
A small team consisting of two patient and public rep-
resentatives and a GP from healthtalk.org [37], reviewed
all healthtalk.org video clips relating to patient experience
of participation in research. Video clips were selected and
edited to illustrate key points from participants talking
about their general experiences of medical research. Each
video clip was edited by the Patient and Public Involve-
ment representatives, working directly with a GP from
healthtalk.org [37], on the basis that the clip reflected a
non-coercive patient perspective on participating in med-
ical studies.
Specially designed infographics (animated information
videos) were developed to accompany the clips in order
to visually explain some of the more difficult concepts
used in medical research (such as randomization). Each
infographic was developed by our digital partners (Rea-
son Digital, Manchester, United Kingdom) based on vis-
ual and text material provided by the research team and
our Patient and Public Involvement representatives, who
all commented extensively on the finished infographic.
The third and final component, study-specific pages,
were designed as a blank template for host trials to in-
sert their own bespoke content, ideally to outline the
purpose of the trial and what it is like to take part. Spe-
cifically, the pages have been split to reflect concerns
raised by potential participants who wish to make an in-
formed decision on participating in the trial. For example,
these pages cover ‘Why are we doing the study and why
do we need your help?’, ‘What will happen during the
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study?’, ‘Questions and answers’, ‘Study care and safety’,
and ‘What happens after the study?’
The plan is for the START team to work with each
host trial team to produce bespoke content for the
study-specific section. The bespoke content is intended
to convey key points about the study in an accessible
form, with templates for video clips of key people in-
volved in the host trial (such as the principal investigator
and trial manager) and previous participants of the trial
describing their experiences (see Figure 3). The platform,
which has been designed to be easily accessed and
navigated by potential participants, is web-based and
viewable on PCs, laptops, and smartphones. Potential
participants will be able to gain access to the multimedia
intervention via a URL and a quick response (QR) code
specific to the host trial placed at the top of the standard
PIS and/or on the patient invitation letter. Potential
participants in each host trial will then be randomized to
either have access to the multimedia intervention in
addition to the standard PIS, or the standard PIS alone.
The MRC START multimedia template can be viewed
online [42].
Work package 3: implementation and analysis
Trial recruitment
Our long-term aim is to embed the concept of embed-
ding recruitment studies into the funding and startup
process of trials in all healthcare settings, and in publicly
and commercially funded trials, in order to ensure that
delivery of embedded recruitment studies is a routine
part of the delivery of trials in the United Kingdom and
elsewhere. In the START program, we will work with
major funders, clinical trials units, and the research net-
work infrastructure in the United Kingdom to identify
and recruit host trials for embedded studies of the re-
cruitment interventions developed in work package 2.
We plan to recruit six trials for each intervention de-
veloped in work package 2 (12 in total). Inclusion cri-
teria for the trial are as follows: trials must be at a stage
in their delivery where adoption of the embedded re-
cruitment intervention is feasible (for example, about to
apply for research ethics approval, early in the recruit-
ment process, or struggling to recruit); trials must be
recruiting from primary care or community settings and
involving recruitment procedures amenable to the inter-
ventions from work package 2; trials must be approaching
at least 800 potential research participants; and there must
be agreement in principle to take part in START, to
randomize using appropriate procedures, to ensure con-
cealment of allocation, deliver the interventions according
to a protocol, and share anonymized data on recruitment
with the START team as part of an ongoing collaboration.
The aim will be to recruit a sample of host trials (see
‘Sample Size’ below) that all approach patients using
broadly comparable recruitment procedures (such as ap-
proaching patients from an existing disease register) but
Figure 2 Web-based platform blank template homepage [42].
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do so in relation to different clinical and health service
areas and in different contexts. We do not expect all tri-
als demonstrating an interest to be able to participate in
START. We will record the process of negotiation and
reasons for participation or non-participation to allow us
to understand barriers and facilitators to the recruitment
of host trials. We will undertake qualitative interviews
with principal investigators and other relevant staff (such
as trial managers) of host trials after completion of the
embedded trial.
Sample size and analysis
Work package 3 is designed to provide two estimates re-
lating to recruitment interventions: (1) the effectiveness
of recruitment interventions in the context of a single
host trial, and (2) a measure of the variability in effect-
iveness across multiple host trials.
A large number of trials in primary care and commu-
nity settings recruit patients with existing health condi-
tions from registers in primary care. For the purposes of
the power calculation, we assume that the primary out-
come is the proportion of potentially eligible patients
who agree to participate following such an invitation.
Therefore, the denominator will be the number of
patients who are initially invited following screening. It
should be noted that this is a larger number than that re-
quired for power for an analysis of the primary outcomes
within individual trials. For example, a trial which is seek-
ing to recruit 300 patients may need to approach approxi-
mately 600 to 1,500, depending on the overall uptake rate.
It is the latter, higher figure which is of relevance for the
power analysis of START in these contexts.
To provide a conservative sample size estimation, we
assume a base response rate of 50% to invitations (al-
though rates in many studies will be significantly lower).
We define a significant improvement in recruitment rate
as an increase in response of 10%. If individual patients
are randomized (for example, to a conventional or opti-
mized participant information sheet), 400 patients per arm
would be required to provide 80% power to detect a 10%
difference (alpha 0.05). We will plan to restrict START to
trials that involve at least this level of recruitment, although
we will not exclude studies where interventions can be in-
troduced after recruitment has begun, or where recruit-
ment continues beyond the end of the START study.
It is anticipated that some trials will prefer to use clus-
ter allocation of the START recruitment interventions,
to ease the logistical burden on the trial and to ensure
Figure 3 Web-based platform study-specific pages blank template.
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the quality of the randomization procedure. We will seek
where possible to ensure that the minimum sample size
is appropriately inflated in these studies to take into ac-
count the cluster allocation, assuming an interclass
correlation of 0.02 in line with recent estimates from
community studies [43,44].
To assess effectiveness of recruitment interventions in
the context of a single host trial, we will seek to analyze
all outcomes of relevance to recruitment, according to
the framework developed in work package 1. It is likely
that the core analysis will involve dichotomous outcomes
(for example randomized or not-randomized) assessed
using logistic regression, and controlling for baseline de-
mographic factors. A generic analysis plan is available
from our statistician (VM). Where possible, we will work
with trials to include additional outcome measures, in-
cluding patient self-reported outcomes such as satisfaction
with information, understanding of the trial, and anxiety.
Although recording of data on retention of randomized
participants is unlikely to be possible during the timeline
of the START study, we will encourage investigators to
collect and report data.
In terms of variability across host trials, we will ex-
plore this in a meta-analytic framework. The proportions
of invited patients recruited into each trial will be en-
tered into a meta-analysis, and the heterogeneity of the
intervention effect across trials will be assessed using
the I2 statistic. If significant heterogeneity is demon-
strated, we will explore differences between trials that
might explain that variation. The power of any such
analyses will be limited because of the small number
of trials, but we will explore this issue qualitatively
using data collected on the trial, the patient popula-
tion, and the context of the study. Analyses will be
guided by a pre-specified analytic plan. All trial data
collected on recruitment and retention facilitated by
START will be disseminated in accordance with the
MRC START publication strategy during the START
funding timeline. Subsequently, data will be captured
and reported by the existing Cochrane reviews to en-
sure their availability outside the START funding and
timeline [11,45].
MRC START has received full ethical approval (Re-
search Ethics Committee: REC Reference: 11/YH/0271)
from the National Research Ethics Service (NRES) Com-
mittee Yorkshire and the Humber - South Yorkshire, and
an MRC START Multimedia Substantial Amendment
covering the generic content in the multimedia interven-
tion (REC reference: 11/YH/0271 substantial amendment
2, 31 October 2013). NRES approval will be obtained for
each embedded study, via a substantial amendment to the
host trial REC.
Patients do not have the opportunity to give informed
consent to enter into the embedded recruitment studies.
This has been approved by NRES Committee Yorkshire
and the Humber - South Yorkshire (REC reference: 11/
YH/0271) on the basis that the embedded studies are not
withholding information, but are just changing the way it
is presented. Each embedded study (standard naming for-
mat: ‘MRC START in [insert host trial name]’) will be reg-
istered by the host study as a sub-study on the relevant
trial registration database.
Preliminary results
To date, we have completed two rounds of recruitment
to START with a third in progress. The recruitment
process was designed to test interest in START and ex-
plore the feasibility of START becoming self-sustaining.
For the first round, trials eligible for START were identi-
fied from the Health Technology Assessment (HTA)
Programme and Primary Care Research Network (PCRN)
databases and sent a START project flyer with a covering
letter from either HTA or PCRN encouraging their par-
ticipation in the START program.
For the second round this procedure was repeated and
followed up by the START project team who attempted
to contact principal investigators up to three times by
phone and a further time by follow-up email. For the
final rounds of recruitment we are using project flyers,
invitation letters, and intensive phone or email follow-up
to establish a more comprehensive picture of the bar-
riers or reasons for non-participation.
Figure 4 shows the first round of recruitment to the
START project. A total of 60 out of 71 potential trials
expressing an interest in START were excluded, primar-
ily due to incompatible recruitment methods or aspects
of the host trial design, indicating considerable scope for
the development of other recruitment interventions. Of
the 11 potential trials identified in the first round of re-
cruitment, 4 became hosts to the PIS intervention, and 7
were subsequently lost due to delays in the development
of the multimedia intervention. The second and third re-
cruitment rounds are ongoing, with 10 of the 12 trials
recruited to date.
There have been some deviations from the protocol in
light of challenges encountered during the work. The
initial plan was to recruit trials in primary care or com-
munity settings and those approaching 800 potential
participants. As the project progressed, these criteria
were relaxed to include secondary care and smaller tri-
als that were keen to participate and had recruitment
procedures amenable to the START interventions. In
one trial the existing PIS was of such high quality that,
in the opinion of experts within the START team, the
PIS development process being evaluated in START
would provide few benefits and the trial was excluded
from START.
Rick et al. Trials 2014, 15:407 Page 8 of 11
http://www.trialsjournal.com/content/15/1/407
Discussion
In the short term, the START program is designed to con-
duct 12 embedded trials of 2 recruitment interventions, in
order to provide a robust assessment of the effects of these
interventions across a range of trial settings.
The program is also designed to develop capacity for
further adoption of the embedded trial methodology,
through development of processes (such as those required
to gain consent from ethical and other governance com-
mittees), resources (such as reporting guidelines and
standardized agreements between researchers from host
and embedded trials), and knowledge (for example,
concerning core barriers to the delivery of embedded
trials, and the optimal methods to encourage adoption).
Initial findings show some difficulty engaging with the
wider trial community. Of the trials approached in the
first round of recruitment, 70% did not respond, al-
though this may reflect the primary care and community
focus evident in the START promotional material. Of
those trials expressing an interest, the majority were in-
eligible. Some reasons for the exclusion of potential host
trials (such as timetable issues, n = 25 in total) are limi-
tations of the timeline for this research and would not in
general be obstacles to testing recruitment interventions
by embedded trial methodology. The fact that over a
third of potential host trials were excluded due to re-
cruitment method or other trial design issues (n = 26)
highlights the need to develop a broader range of
recruitment interventions suitable to varying trial re-
cruitment methods. Further adoption and implementa-
tion of the START model is likely to be dependent on
the ongoing development of tools and interventions that
can be tested using the embedded trials approach, in-
cluding interventions for professionals [11,46]. However,
as noted earlier, this may lead to additional logistical chal-
lenges in implementing embedded recruitment studies
which may not be fully explored in the current START
protocol, with its focus on lower complexity, patient-level
interventions. The development of appropriate incentives
to encourage adoption of these methods by busy trial
teams is also likely to be important. The more intensive
follow-up work on barriers to participation, conducted in
the second and third recruitment rounds, will inform de-
velopment in this area.
The START program will in turn contribute to other
developing resources around trials methodology, such as
Studies Within A Trial (SWAT [47]) and Trial Forge
[48], to meet the longer term aim of making the delivery
of embedded recruitment trials routine, and to make a
substantive contribution to the development of a science
of recruitment.
Trial status
Recruitment began in March, 2012. The second and
third recruitment rounds are ongoing, with 10 of the 12
trials recruited to date.
Trials identified through database 
searching & invited to participate 





























Potential host trials responding to 
invitation 
(n = 71, 31.5%) 
Eligible trials 
(n = 11 ) 
Trials excluded
(n = 60) 
Recruitment 21 
Trial closed 9 
Timetable 9 
Sample size 5 
Trial design 5 
Withdrew 5 
Other  6 
Included trials 
(n = 4 ) 
Eligible trials excluded
(n =7) 
Timing issues 7 
No Response
(n=154, 68.5%) 
Figure 4 Round 1 recruitment outcomes.
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